Detection of Novel US Neisseria meningitidis Urethritis Clade Subtypes in Japan.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC) Country of Publication: United States NLM ID: 9508155 Publication Model: Print Cited Medium: Internet ISSN: 1080-6059 (Electronic) Linking ISSN: 10806040 NLM ISO Abbreviation: Emerg Infect Dis Subsets: MEDLINE
    • Publication Information:
      Original Publication: Atlanta, GA : National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC), [1995-
    • Subject Terms:
    • Abstract:
      Neisseria meningitidis causes invasive meningococcal diseases and has also been identified as a causative agent of sexually transmitted infections, including urethritis. Unencapsulated sequence type 11 meningococci containing the gonococcal aniA-norB locus and belonging to the United States N. meningitidis urethritis clade (US_NmUC) are causative agents of urethral infections in the United States, predominantly among men who have sex with men. We identified 2 subtypes of unencapsulated sequence type 11 meningococci in Japan that were phylogenetically close to US_NmUC, designated as the Japan N. meningitidis urethritis clade (J_NmUC). The subtypes were characterized by PCR, serologic testing, and whole-genome sequencing. Our study suggests that an ancestor of US_NmUC and J_NmUS urethritis-associated meningococci is disseminated worldwide. Global monitoring of urethritis-associated N. meningitidis isolates should be performed to further characterize microbiologic and epidemiologic characteristics of urethritis clade meningococci.
    • References:
      Infect Immun. 2001 Nov;69(11):6912-22. (PMID: 11598066)
      Vaccine. 2016 Jul 25;34(34):4068-71. (PMID: 27291085)
      Vaccine. 2023 Jan 9;41(2):416-426. (PMID: 36464540)
      PLoS One. 2016 May 11;11(5):e0154047. (PMID: 27167067)
      Science. 2000 Mar 10;287(5459):1809-15. (PMID: 10710307)
      FEMS Immunol Med Microbiol. 2008 Jan;52(1):36-46. (PMID: 17995962)
      MMWR Morb Mortal Wkly Rep. 2016 Sep 09;65(35):939-40. (PMID: 27606798)
      Bioinformatics. 2018 Mar 15;34(6):1037-1039. (PMID: 29106469)
      MMWR Morb Mortal Wkly Rep. 2016 Jun 03;65(21):550-2. (PMID: 27254649)
      J Clin Microbiol. 2021 Jan 21;59(2):. (PMID: 33177123)
      Vaccine. 2016 Mar 18;34(13):1515-1523. (PMID: 26876439)
      J Clin Microbiol. 2007 Nov;45(11):3768-70. (PMID: 17728467)
      Infect Immun. 2023 May 16;91(5):e0007923. (PMID: 37092998)
      Open Forum Infect Dis. 2022 Dec 12;10(1):ofac661. (PMID: 36655188)
      Microbiol Spectr. 2022 Jun 29;10(3):e0062722. (PMID: 35467371)
      IUBMB Life. 2008 Sep;60(9):629-36. (PMID: 18618739)
      Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):3140-5. (PMID: 9501229)
      Microb Pathog. 1994 Feb;16(2):153-63. (PMID: 7913984)
      BMC Bioinformatics. 2010 Dec 10;11:595. (PMID: 21143983)
      Emerg Infect Dis. 2015 Aug;21(8):1379-86. (PMID: 26197087)
      J Clin Microbiol. 2017 Dec;55(12):3374-3383. (PMID: 28904187)
      Clin Infect Dis. 2017 Sep 01;65(5):756-763. (PMID: 28505234)
      Emerg Infect Dis. 2019 May;25(5):972-975. (PMID: 31002061)
      Clin Sci (Lond). 2010 Feb 09;118(9):547-64. (PMID: 20132098)
      Bioinformatics. 2015 Nov 15;31(22):3691-3. (PMID: 26198102)
      Expert Rev Vaccines. 2022 May;21(5):659-674. (PMID: 35271781)
      BMC Genomics. 2018 Mar 2;19(1):176. (PMID: 29499642)
      Curr Opin Infect Dis. 2021 Feb 1;34(1):34-39. (PMID: 33278178)
      Microb Genom. 2016 Apr 29;2(4):e000056. (PMID: 28348851)
      PLoS One. 2013;8(2):e55798. (PMID: 23405216)
      J Clin Microbiol. 2022 Nov 16;60(11):e0057522. (PMID: 35969045)
      Proc Natl Acad Sci U S A. 2017 Apr 18;114(16):4237-4242. (PMID: 28373547)
      Trends Microbiol. 2023 Aug;31(8):805-815. (PMID: 36941192)
      PLoS Comput Biol. 2017 Jun 8;13(6):e1005595. (PMID: 28594827)
      Infect Immun. 2010 Sep;78(9):3832-47. (PMID: 20584970)
      Euro Surveill. 2020 Apr;25(15):. (PMID: 32317054)
      Nucleic Acids Res. 2021 Jul 2;49(W1):W293-W296. (PMID: 33885785)
      J Infect Dis. 1993 Feb;167(2):475-9. (PMID: 8380612)
      J Med Microbiol. 2004 Jul;53(Pt 7):657-662. (PMID: 15184538)
      Mol Microbiol. 1992 Oct;6(19):2785-95. (PMID: 1435257)
      Microbiology (Reading). 2009 Dec;155(Pt 12):4093-4103. (PMID: 19762442)
      Emerg Infect Dis. 2023 Oct;29(10):2130-2134. (PMID: 37735771)
      PLoS One. 2021 Nov 29;16(11):e0260677. (PMID: 34843604)
      Genome Biol. 2019 Jun 24;20(1):129. (PMID: 31234903)
      Proc Natl Acad Sci U S A. 2016 Mar 8;113(10):2714-9. (PMID: 26888286)
      J Clin Microbiol. 2000 Feb;38(2):855-7. (PMID: 10655397)
      Expert Rev Vaccines. 2019 Jan;18(1):15-30. (PMID: 30526162)
      Euro Surveill. 2013 Jul 11;18(28):. (PMID: 23870095)
      Emerg Infect Dis. 2017 Feb;23(2):336-339. (PMID: 28098538)
    • Grant Information:
      United Kingdom WT_ Wellcome Trust
    • Contributed Indexing:
      Keywords: Japan; Neisseria meningitidis; bacteria; invasive meningococcal diseases; meningitis/encephalitis; meningococci; phylogenetic analysis; serogroup; sexually transmitted infections; urethritis; urethritis clade; whole-genome sequencing
    • Publication Date:
      Date Created: 20231025 Date Completed: 20231026 Latest Revision: 20231205
    • Publication Date:
      20231205
    • Accession Number:
      PMC10617353
    • Accession Number:
      10.3201/eid2911.231082
    • Accession Number:
      37877502